Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PLX > SEC Filings for PLX > Form 8-K on 18-Jun-2014All Recent SEC Filings

Show all filings for PROTALIX BIOTHERAPEUTICS, INC.

Form 8-K for PROTALIX BIOTHERAPEUTICS, INC.


18-Jun-2014

Other Events


Item 8.01. Other Events

On June 18, 2014, Protalix BioTherapeutics, Inc. (the "Company") issued a press release announcing that the first Gaucher patient has been enrolled in the Company's phase IIa clinical trial of oral glucocerebrosidase (GCD) (PRX-112) for the treatment of Gaucher disease. A copy of the press release is filed as Exhibit 99.1.

  Add PLX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PLX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.